| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
428 | 597 | 1,128 | 1,764 | 1,530 |
| Cost of Revenue
|
-1,228 | -1,359 | -1,341 | -1,541 | -985 |
|
Gross Profit
|
-800 | -762 | -213 | 223 | 545 |
| Selling, General and Administrative Expenses
|
-4,921 | -5,555 | -6,033 | -5,739 | -4,600 |
|
Exploration Expenses
|
-1,798 | -1,584 | -537 | -377 | -864 |
|
Accretion of Asset Retirement Obligation
|
-80 | -80 | -1 | -10 | -1 |
|
Operating Income/Expenses
|
-6,757 | -7,219 | -6,571 | -6,126 | -5,465 |
|
Total Operating Profit/Loss
|
-7,557 | -7,981 | -6,784 | -5,903 | -4,920 |
| Total Net Finance Income/Expense
|
-4,715 | -3,928 | -1,748 | -1,377 | -1,083 |
| Net Investment Income
|
883 | 1,850 | 1,122 | 1,076 | -545 |
| Irregular Income/Expenses
|
20 | 0 | 58 | 38 | 0 |
|
Other Income/Expense, Non-Operating
|
371 | 844 | 0 | -- | 0 |
|
Non-Operating Income/Expenses, Total
|
-3,441 | -1,234 | -568 | -263 | -1,628 |
|
Pretax Income
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,548 |
| Provision for Income Tax
|
0 | 0 | 0 | 0 | -270 |
|
Net Income from Continuing Operations
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,818 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,818 |
|
Net Income after Non-Controlling/Minority Interests
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,818 |
|
Net Income Available to Common Stockholders
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,818 |
|
Diluted Net Income Available to Common Stockholders
|
-10,998 | -9,215 | -7,352 | -6,166 | -6,818 |
| Basic EPS
|
-0.48 | -0.38 | -0.48 | -0.27 | -0.44 |
| Diluted EPS
|
-0.48 | -0.38 | -0.48 | -0.27 | -0.44 |
|
Basic Weighted Average Shares Outstanding
|
23,504.5000 | 21,637 | 20,118 | 20,063 | 17,290 |
|
Diluted Weighted Average Shares Outstanding
|
23,504.5000 | 21,637 | 20,118 | 20,063 | 17,290 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-9,468 | -7,721 | -6,414 | -5,710 | -6,220 |
|
EBITDA
|
-8,651 | -6,916 | -5,796 | -5,235 | -5,934 |
|
Normalized EBITDA
|
-10,227 | -7,034 | -6,443 | -4,853 | -3,414 |
|
Normalized Income
|
-12,574 | -9,333 | -7,999 | -5,784 | -5,306 |
|
Total Unusual Items
|
-1,576 | -118 | -647 | 382 | 2,520 |
12/31/2022 - 9/9/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade